BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35402524)

  • 1. Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy.
    Sun J; Liang L; Li P; Jiang T; Yu X; Ren C; Dong R; He J
    Front Cardiovasc Med; 2022; 9():855491. PubMed ID: 35402524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy.
    Li P; Xue Y; Sun J; Chen M; Yu X; Zhao H; Gao Y; Zhang X; Jiang T; He J
    Clin Cardiol; 2021 Oct; 44(10):1409-1415. PubMed ID: 34302367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of alcohol septal ablation in mildly symptomatic or severely symptomatic patients with hypertrophic obstructive cardiomyopathy].
    Sun JJ; Li PJ; Yu XP; Zhao H; Zhang XL; Tu CC; Zhang MD; Jiang TY; Song XT; He JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):513-520. PubMed ID: 37198123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy].
    Li PJ; Sun JJ; Chen ML; Yu XP; Zhao H; Gao YC; Zhang XL; Jiang TY; He JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):369-374. PubMed ID: 35399033
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy.
    Meng X; Liang M; Shi Y; Zhang W; Zhou S; Gao C
    Anatol J Cardiol; 2020 Jun; 23(6):342-348. PubMed ID: 32478684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
    J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Bytyçi I; Nistri S; Mörner S; Henein MY
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32977442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
    Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
    J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and midterm results of extended septal myectomy: Indian experience.
    Kumar N; Kanna S; Goel H; Mohanty A; Mohan R; Dubey S; Shad S
    J Card Surg; 2021 Dec; 36(12):4465-4471. PubMed ID: 34532892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
    Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
    Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
    Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
    Cavigli L; Fumagalli C; Maurizi N; Rossi A; Arretini A; Targetti M; Passantino S; Girolami F; Tomberli B; Baldini K; Tomberli A; Antoniucci D; Yacoub MH; Marchionni N; Stefano PL; Cecchi F; Olivotto I
    Int J Cardiol; 2018 Dec; 273():155-161. PubMed ID: 30213605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDDR pacing for symptomatic patients with hypertrophic obstructive cardiomyopathy: The first experience in the Netherlands with pacing in HOCM.
    Achterberg HJ; Scheffer MG; van Mechelen R; Kofflard MJ; Ten Cate FJ
    Neth Heart J; 2002 Jun; 10(6):272-276. PubMed ID: 25696108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
    Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
    J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy.
    Fernandez R; Nappi F; Horvath SA; Guigui SA; Mihos CG
    Rev Cardiovasc Med; 2021 Sep; 22(3):983-990. PubMed ID: 34565099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
    Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
    J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience.
    Kotkar KD; Said SM; Dearani JA; Schaff HV
    Ann Cardiothorac Surg; 2017 Jul; 6(4):329-336. PubMed ID: 28944173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.
    Sorajja P; Nishimura RA; Gersh BJ; Dearani JA; Hodge DO; Wiste HJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):234-41. PubMed ID: 19589436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
    Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
    Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and Mid-Term Outcomes of Early Alcohol Septal Ablation Therapy for Patients with Mildly Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Tertiary Center Experience.
    Oktay V; Arslan S; Gecit MH; Bulat Z; Gokce ME
    J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.